Research Article
Pharmacokinetics of Ginsenoside Rb1, Rg3, Rk1, Rg5, F2, and Compound K from Red Ginseng Extract in Healthy Korean Volunteers
Figure 4
Representative multiple reaction monitoring (MRM) chromatograms of ginsenosides: (a) ginsenoside Rb1, (b) ginsenoside Rg3, (c) ginsenoside Rg5 (Rk1), (d) ginsenoside F2, (e) compound K, and (f) digoxin (IS) in human double blank plasma, blank plasma containing IS, blank plasma containing ginsenosides of LLOQ and IS, and plasma sample near Cmax after a single administration of bioconverted red ginseng extract. IS, internal standard; LLOQ, lower limit of quantitation; Cmax, maximum concentration; RT, retention time.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |